Chicago Bridge & Iron Company N.V.
) recently announced that it has received a contract from Pesky
Koncern Naftowy Orlen S.A. (PKN). CBI will be providing engineering
services for licensing and designing of PKN's forthcoming
on-purpose propylene production facility in Plock, Poland. The
announcement on Aug 21 did not provide much momentum to the stock
that has gained about 1.2% so far.
The contract entails CBI to utilize its Olefins Conversion
Technology (OCT) to aid the production of 100,000 metric tons per
annum (MTA) of propylene. OCT is the proprietary technology of the
company's Lummus Novolen Technology GmbH (Novolen) subsidiary for
producing polymer grade propylene.
The technology, designed to deal with a diverse range of
feedstock compositions, will utilize the same from PKN's Refinery
and Petrochemical Complex at Plock. This apart, OCT not only
produces high quality propylene, but also reduces the recurring
CBI is the leading provider of integrated engineering,
procurement and construction services across the globe. Recently,
the company reported second-quarter 2014 results with adjusted
earnings of $1.36 per share that surpassed the Zacks Consensus
Estimate of $1.27 by 7.1%. Revenues for the quarter came in
at $3.3 billion, reflecting year-over-year growth of 15.6%.
Chicago Bridge & Iron currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the sector include Willdan Group Inc.
), Blount International Inc. (
) and VSE Corp. (
). While Willdan Group and Blount International sport a Zacks Rank
#1 (Strong Buy), VSE has a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
CHICAGO BRIDGE (CBI): Free Stock Analysis
WILLDAN GROUP (WLDN): Get Free Report
VSE CORP (VSEC): Free Stock Analysis Report
BLOUNT INTL (BLT): Free Stock Analysis Report
To read this article on Zacks.com click here.